KDDD 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KUS121 / KDDD
GION, NCT06178055: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)

Active, not recruiting
2
75
US
KUS121 high dose, KUS121 low dose, Sham procedure
Kyoto Drug Discovery and Development Co., Ltd.
Central Retinal Artery Occlusion
03/25
12/25

Download Options